Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 601–700 of 1,002
Gårdebjer, E. M., Anderson, S. T., Pantaleon, M., Wlodek, M. E., & Moritz, K. M. (2015) · The FASEB Journal · doi:10.1096/fj.14-268979 · Cited by 67
“This metabolic phenotype was associatedwith increased hepatic gluconeogenesis in both sexes, indicated by increased levels of G6pc, Pck1, and Ppargc1a and decreased levels of Gck mRNA, although increased fasting glucose concentrations was only apparent in males.”
BackgroundInfluentialCoulter, A. A., Bearden, C. M., Liu, X., Koza, R. A., & Kozak, L. P. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00057.2003 · Cited by 62
Aatsinki, S.-M., Elkhwanky, M.-S., Kummu, O., Karpale, M., Buler, M., Viitala, P., Rinne, V., Mutikainen, M., Tavi, P., Franko, A., et al. (2019) · Diabetes · doi:10.2337/db18-1050 · Cited by 61
“GR is also a known interaction partner for PGC-1a (34).”
BackgroundHepatic gene expression patterns in thyroid hormone-treated hypothyroid rats
Weitzel, J., Hamann, S., Jauk, M., Lacey, M., Filbry, A., Radtke, C., Iwen, K., Kutz, S., Harneit, A., Lizardi, P., et al. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310291 · Cited by 65
“…CREB, HCF or HNF-4 (either transcriptional regulators of late-induced genes or PGC-1 interaction partners (Evans & Scarpulla 1989, Basu et al. 1993, Seelan & Grossman 1997, Tagami et al. 1999, Zaid et al. 1999, Yoon et al. 2001, Lin et al. 2002)) have been shown to be regulated by T3 (Table 3).”
BackgroundMartínez-Jiménez, C. P., Castell, J. V., Gómez-Lechón, M. J., & Jover, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025403 · Cited by 66
“Under fasting conditions however, glucagon, cAMP, and glucocorticoids induce PGC1 expression, leading to the activation of all key enzymes of gluconeogenesis and the increase of hepatic glucose production (Yoon et al., 2001).”
BackgroundRole of PGC-1α in exercise and fasting-induced adaptations in mouse liver
Haase, T. N., Ringholm, S., Leick, L., Biensø, R. S., Kiilerich, K., Johansen, S., Nielsen, M. M., Wojtaszewski, J. F., Hidalgo, J., Pedersen, P. A., et al. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00775.2010 · Cited by 66
Silva, J., Spatz, M. H., Folk, C., Chang, A., Cadenas, E., Liang, J., & Davies, D. L. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.10.002 · Cited by 67
The multiple roles of salt-inducible kinases in regulating physiology
Jagannath, A., Taylor, L., Ru, Y., Wakaf, Z., Akpobaro, K., Vasudevan, S. R., & Foster, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00023.2022 · Cited by 69
Im, S.-S., Kim, M.-Y., Kwon, S.-K., Kim, T.-H., Bae, J.-S., Kim, H., Kim, K.-S., Oh, G.-T., & Ahn, Y.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157875 · Cited by 64
Baicalin reduces mitochondrial damage in streptozotocin‐induced diabetic Wistar rats
Waisundara, V. Y., Hsu, A., Tan, B. K., & Huang, D. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1005 · Cited by 66
“The fragmentation of mitochondria, through fission, facilitates the release of mitochondrial proteins and metabolites such as ROS and RNS that trigger intracellular oxidative stress and cell death [34].”
BackgroundInoue, E., & Yamauchi, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.124 · Cited by 71
Gene expression profiling of liver from dairy cows treated intra-mammary with lipopolysaccharide
Jiang, L., Sørensen, P. B., Røntved, C. M., Vels, L., & Ingvartsen, K. L. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-443 · Cited by 74
“Activation of AMPK leads to inhibition of glucose production and we did indeed observe decreased expression of the gluconeogenic key enzymes PCK1 and G6PC and their transcriptional co-activator PGC-1α [52].”
BackgroundUncoupled iron homeostasis in type 2 diabetes mellitus
Altamura, S., Kopf, S., Schmidt, J., Müdder, K., da Silva, A. R., Nawroth, P. P., & Muckenthaler, M. U. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1596-3 · Cited by 67
Liang, X., Yee, S. W., Chien, H., Chen, E. C., Luo, Q., Zou, L., Piao, M., Mifune, A., Chen, L., Calvert, M., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002907 · Cited by 66
“Higher pyruvate levels can drive hepatic gluconeogenesis, resulting in increased hepatic glucose production and associated increases in hepatic glucose and glycogen levels [1, 52].”
BackgroundRegulation of hepatocyte identity and quiescence
Berasain, C., & Avila, M. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1970-7 · Cited by 68
Zhang, F., Xu, X., Zhou, B., He, Z., & Zhai, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027553 · Cited by 62
“hepatic gluconeogenesis controllers such as PGC1 and SIRT1, are altered by nutritional status and considered as drug targets for diabetes and obesity [18,19].”
BackgroundDecreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms
Untereiner, A. A., Wang, R., Ju, Y., & Wu, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6369 · Cited by 65
“It has been reported that under starvation conditions, PGC1a and PEPCK are significantly upregulated in mouse liver (15, 38).”
BackgroundMethodInfluentialStallcup, M. R., & Poulard, C. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.02.006 · Cited by 68
The Shc locus regulates insulin signaling and adiposity in mammals
Tomilov, A. A., Ramsey, J. J., Hagopian, K., Giorgio, M., Kim, K. M., Lam, A., Migliaccio, E., Lloyd, K. C., Berniakovich, I., Prolla, T. A., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00641.x · Cited by 64
“Insulin-inhibitable glucose release was assayed similarly as described (Yoon et al., 2001; Li et al., 2007).”
MethodKang, Y. K., Putluri, N., Maity, S., Tsimelzon, A., Ilkayeva, O., Mo, Q., Lonard, D., Michailidis, G., Sreekumar, A., Newgard, C. B., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005116 · Cited by 49
“Also, CAPER is induced when high levels of nutrients are present, in contrast to PGC-1α which is induced upon fasting [32].”
BackgroundSelf-citationHormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Tao, Z., & Cheng, Z. (2023) · Clinical Science · doi:10.1042/cs20210519 · Cited by 74
Prakash, P., Singh, V., Jain, M. K., Rana, M., Khanna, V., Barthwal, M. K., & Dikshit, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.038 · Cited by 65
The Relationship between Selenoprotein P and Glucose Metabolism in Experimental Studies
Mao, J., & Teng, W. (2013) · Nutrients · doi:10.3390/nu5061937 · Cited by 67
“High-level transcription of the Sepp1 gene in liver is ensured by the combined action of FoxO1a and HNF-4α with the coactivator (PGC)-1α.”
BackgroundInfluentialMetabolic Activity of Radish Sprouts Derived Isothiocyanates in Drosophila melanogaster
Baenas, N., Piegholdt, S., Schloesser, A., Moreno, D. A., García‐Viguera, C., Rimbach, G. H., & Wagner, A. E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020251 · Cited by 69
“Interestingly, PGC-1α has been suggested to be involved in the regulation of glucose homeostasis in mammals [23,24].”
BackgroundWang, M., Luo, L., Yao, L., Wang, C., Jiang, K., Liu, X., Xu, M., Shen, N., Guo, S., Sun, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25399 · Cited by 65
Transcriptional Regulation of CYP2D6 Expression
Pan, X., Ning, M., & Jeong, H. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072249 · Cited by 71
“For example, enhanced expression of PPAR coactivator (PGC) 1 (a coactivator of HNF4 ) by glucagon leads to elevated expression of HNF4 target genes (Yoon et al., 2001). cDNA microarray experiments using liver tissues of tg-CYP2D6 mice collected at different gestational time points revealed one…”
BackgroundSrivastava, S., Barrett, J. N., & Moraes, C. T. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm045 · Cited by 63
“Unlike PGC-1β, PGC-1α expression activates genes involved in gluconeogenesis (57), whereas PGC-1β expression activates genes involved in β-oxidation of fatty acids (29,58) implicating their distinct roles in energy metabolism.”
BackgroundThe master energy homeostasis regulator PGC-1α exhibits an mRNA nuclear export function
Mihaylov, S. R., Castelli, L. M., Lin, Y.-H., Gül, A., Soni, N., Hastings, C., Flynn, H. R., Păun, O., Dickman, M. J., Snijders, A. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41304-8 · Cited by 63
Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators
Fadel, L., Dacic, M., Fonda, V., Sokolsky, B. A., Quagliarini, F., Rogatsky, I., & Uhlenhaut, N. H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108531 · Cited by 65
Human cytomegalovirus infection increases mitochondrial biogenesis
Kaarbø, M., Ager-Wick, E., Osenbroch, P. Ø., Kilander, A., Skinnes, R., Müller, F., & Eide, L. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.08.008 · Cited by 66
In vivo role of the HNF4α AF‐1 activation domain revealed by exon swapping
Briançon, N., & Weiss, M. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601021 · Cited by 70
“This induction was normal (Figure 5C), as expected since neoglu- cogenic genes are reported to be induced through coactivation with PGC1a, which interacts with the AF-2 domain common to both HNF4a isoforms (Yoon et al, 2001).”
BackgroundCyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α
Bhalla, K., Liu, W.-J., Thompson, K. N., Anders, L., Devarakonda, S., Dewi, R. E., Buckley, S., Hwang, B., Polster, B. M., Dorsey, S. G., et al. (2014) · Diabetes · doi:10.2337/db13-1283 · Cited by 66
Kulozik, P., Jones, A., Mattijssen, F., Rose, A. J., Reimann, A., Strzoda, D., Kleinsorg, S., Raupp, C., Kleinschmidt, J. A., Müller‐Decker, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.011 · Cited by 73
“particularly the differential gene expression of specific transcriptional regulators between healthy and metabolic disease conditions has been found to often reflect a causal, functional role of these factors in the pathogenesis of type 2 diabetes, cancer cachexia, and obesity, respectively (Berriel Diaz et al., 2008;…”
BackgroundInfluentialRole of Nuclear Receptors in Central Nervous System Development and Associated Diseases
Ana Maria, A., Oscar Andréas, M.-R., & Haider, N. B. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25480 · Cited by 59
Proteome analysis of adipogenesis
Welsh, G. I., Griffiths, M. R., Webster, K., Pagé, M., & Tavaré, J. M. (2004) · PROTEOMICS · doi:10.1002/pmic.200300675 · Cited by 67
Skin phototype: a new perspective
Maresca, V., Flori, E., & Picardo, M. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12365 · Cited by 60
“…impinges on the peroxisome proliferator-activated recep- tor gamma coactivator proteins (PGC-1s), transcriptional coactivators of most of the nuclear receptors, and thereby playing important roles in numerous metabolic processes (Chinsomboon et al., 2009; Spiegelman, 2007; Yoon et al., 2001).”
BackgroundSkeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis
Little, J. P., Safdar, A., Benton, C. R., & Wright, D. C. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-076 · Cited by 63
“At least in skeletal muscle and liver, PGC-1a controls the expression of PDK4 and PEPCK (Yoon et al. 2001; Wende et al. 2007), enzymes that function in adipocytes as essential components of glyceroneogenesis (Cadoudal et al.”
BackgroundHwang, B., Jeoung, N. H., & Harris, R. A. (2009) · Biochemical Journal · doi:10.1042/bj20090390 · Cited by 63
Nuclear Receptors: Nomenclature, Ligands, Mechanisms of Their Effects on Gene Expression
Smirnov, A. N. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1020545200302 · Cited by 73
The Regulation of HBV Transcription and Replication
Oropeza, C. E., Tarnow, G., Sridhar, A., Taha, T. Y., Shalaby, R. E., & McLachlan, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9151-4_3 · Cited by 62
Díaz, M. B., Krones, A., Metzger, D., Ziegler, A., Vegiopoulos, A., Klingenspor, M., Müller‐Decker, K., & Herzig, S. (2008) · Hepatology · doi:10.1002/hep.22383 · Cited by 68
Zhu, L., Sun, G., Zhang, H., Zhang, Y., Chen, X., Jiang, X., Jiang, X., Krauss, S., Zhang, J., Xiang, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004182 · Cited by 63
“PGC-1a plays important roles in many physiological processes, including adipocyte cell differentiation [13], the regulation of adaptive thermogenesis in brown fat and muscle [13,16], control of hepatic gluconeogenesis [17], fuel selection in skeletal muscle cells [18], and suppression of reactive oxygen”
BackgroundHu, X., Du, S., Tunca, C., Braden, T., Long, K. R., Lee, J., Webb, E. G., Dietz, J. D., Hummert, S., Rouw, S., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1447 · Cited by 63
Bhat, A., Koul, A., Rai, E., Sharma, S., Dhar, M. K., & Bamezai, R. N. K. (2007) · Human Genetics · doi:10.1007/s00439-007-0352-0 · Cited by 68
“…and nuclear respiratory factor (NRF)-dependent transcription, GLUT4 expression in skeletal muscles (Michael et al. 2001), gluconeogenesis in liver (Yoon et al. 2001), expression of both nuclear and mitochondrialencoded genes of oxidative metabolism, mitochondrial biogenesis, and energy…”
BackgroundWang, R., Pan, R., Zhang, W., Fu, J., Lin, J. D., & Meng, Z. (2017) · Protein & Cell · doi:10.1007/s13238-017-0442-2 · Cited by 63
“…coactivator for nuclear hormone receptors and other transcriptional factors that regulates several major metabolic pathways including mitochondrial oxidative phosphorylation (OXPHOS) (Wu et al., 1999; Lehman et al., 2000) and hepatic gluconeogenesis (Herzig et al., 2001; Yoon et al., 2001).”
BackgroundLee, H., Choi, J. S., Lee, H. J., Kim, W., Park, S. I., & Song, J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.008 · Cited by 65
“PGC-1α and hepatocyte nuclear factor-4α are highly enriched in the liver and are well-known coactivators of PEPCK expression [34].”
BackgroundRegulation of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1α
Bianchi, K., Vandecasteele, G., Carli, C., Romagnoli, A., Szabadkai, G., & Rizzuto, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401784 · Cited by 60
Pashkov, V., Huang, J., Parameswara, V., Kędzierski, W., Kurrasch, D. M., Tall, G. G., Esser, V., Gerard, R. D., Uyeda, K., Towle, H. C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216234 · Cited by 70
Shin, H., Park, Y., Kim, S.-U., Moon, H., Park, D., Han, Y., Lee, C., Lee, D., Song, I.-S., Lee, D. H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259978 · Cited by 62
Cao, H., van der Veer, E., Ban, M. R., Hanley, A. J., Zinman, B., Harris, S. B., Young, T. K., Pickering, J. G., & Hegele, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031361 · Cited by 64
“The dependence of insulin suppression of PCK1 expression on PGC-1 was also suggested by induction of PGC-1 expression in both type 2 DM and mice with a disrupted insulin receptor gene (25).”
BackgroundDefinition of the Molecular Basis for Estrogen Receptor-Related Receptor-α-Cofactor Interactions
Gaillard, S., Dwyer, M. A., & McDonnell, D. P. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0179 · Cited by 58
Yamagata, K. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.491 · Cited by 66
“Phosphoenol pyruvate carboxykinase (PEPCK), which is a key enzyme of gluconeogenesis, is an important target of HNF-4 in the liver [39].”
BackgroundDonato, M. T., & Gómez-Lechón, M. J. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850001 · Cited by 64
Ikeda, S., Kawamoto, H., Kasaoka, K., Hitomi, Y., Kizaki, T., Sankai, Y., Ohno, H., Haga, S., & Takemasa, T. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01623.x · Cited by 59
“…mitochondrial gene expression in C2C12 myocytes (Wu et al. 1999, Michael et al. 2001), 3T3 adipocytes (Puigserver et al. 1998), primary hepatocytes (Yoon et al. 2001) 2006 The Authors Journal compilation 2006 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2006.01623.x 217 and cardiac…”
BackgroundInfluentialHandschin, C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003641074 · Cited by 56
“For example, hepatic gluconeogenesis is constitutively elevated in global PGC-1α knockout mice (67) whereas liver-specific PGC-1α knockout animals exhibit reduced fasting-induced glucose production in the liver (75), as expected from previous gain-of-function studies (91).”
BackgroundSaboori, S., Koohdani, F., Nematipour, E., Rad, E. Y., Saboor‐Yaraghi, A. A., Javanbakht, M. H., Eshraghian, M., Ramezani, A., & Djalali, M. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.11.013 · Cited by 64
Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor κB pathway
Nikolaidou-Neokosmidou, V., Zannis, V. I., & Kardassis, D. (2006) · Biochemical Journal · doi:10.1042/bj20060169 · Cited by 61
Vaughan, R. A., Garcia-Smith, R., Bisoffi, M., Conn, C. A., & Trujillo, K. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.009 · Cited by 58
A Balance of Lipid-Sensing Mechanisms in the Brain and Liver
Caspi, L., Wang, P. Y. T., & Lam, T. K. T. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.005 · Cited by 58
Wu, K., Huang, C., Shi, X., Chen, F., Xu, Y., Pan, Y., Luo, Z., & Liu, X. (2016) · Scientific Reports · doi:10.1038/srep38716 · Cited by 58
Huang, D., Liang, H., Ren, M., Ge, X., Ji, K., Yu, H., & Maulu, S. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.735806 · Cited by 60
Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches
Rector, R. S., Payne, R. M., & Ibdah, J. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.014 · Cited by 58
“Liver PGC-1α and PGC-1β expression is low in normal conditions, but is upregulated with fasting and in response to metabolic stress [60-62].”
BackgroundSong, S., & Hwang, E. (2018) · Cells · doi:10.3390/cells8010011 · Cited by 57
Farida, E., Nuraida, L., Giriwono, P. E., & Jenie, B. S. L. (2020) · International Journal of Food Science · doi:10.1155/2020/6108575 · Cited by 64
“G6pc and Pepck are important enzymes in gluconeogenesis which are activated by glucagon and inactivated by insulin [47].”
BackgroundDröge, W., & Kinscherf, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1953 · Cited by 57
“PGC-1 is strongly induced upon fasting (115, 202),”
Cao, L., Li, Y. S., Smirnov, A., Voshtani, R., Wang, T., Shao, C., Candi, E., Melino, G., Shi, Y., & Fang, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01519-2 · Cited by 58
“PGC-1α expression is controlled by several signaling pathways, including of calcium signaling [17– 19], calcineurin A [18], cyclic AMP [20, 21], AMP-activated protein kinase (AMPK) [21] and insulin [22].”
Qiao, L., MacDougald, O. A., & Shao, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603038200 · Cited by 56
Qiao, L., MacLean, P. S., You, H., Schaack, J. B., & Shao, J. (2006) · Endocrinology · doi:10.1210/en.2005-1507 · Cited by 57
Shen, L., Haas, M., Wang, D. Q. ‐., May-Zhang, A. A., Lo, C. C., Obici, S., Tso, P., Woods, S. C., & Liu, M. (2015) · Physiological Reports · doi:10.14814/phy2.12543 · Cited by 57
“Insulin inhibits gluconeogenesis by suppressing the expression of both of Pepck and glu-6-pase, which are key enzymes of hepatic gluconeogenesis (Yoon et al. 2001).”
BackgroundNutrient regulation of glucagon secretion: involvement in metabolism and diabetes
Marroquí, L., Alonso-Magdalena, P., Merino, B., Fuentes, E., Nadal, A., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 54
“activation of the cAMP response element-binding protein and PPARg-coactivator-1((110,112)).”
BackgroundFang, P., He, B., Yu, M., Shi, M., Zhu, Y. N., Zhang, Z., & Bo, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.002 · Cited by 57
Martínez-Jiménez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604046200 · Cited by 58
Evidence of an association between genetic variation of the coactivator PGC-1β and obesity
Andersen, G., Wegner, L., Yanagisawa, K., Rose, C. S., Lin, J. D., Glümer, C., Drivsholm, T., Borch-Johnsen, K., Jørgensen, T., Hansen, T. F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.026278 · Cited by 58
Self-citationBeaudry, J.-B., Pierreux, C. E., Hayhurst, G. P., Plumb-Rudewiez, N., Weiss, M. C., Rousseau, G. G., & Lemaigre, F. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02445-05 · Cited by 56
“HNF-4 is, together with PGC-1 , a key mediator of hormonal control of g6pc expression (49).”
BackgroundVaughan, R. A., Garcia-Smith, R., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2012) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s10233 · Cited by 55
Yao, X., Chen, L., & Nyomba, B. L. G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01115.2005 · Cited by 61
“PGC-1 is not significantly expressed in the liver in the fed state but is readily detectable after fasting and in states of diminished insulin action where gluconeogenesis is increased (21, 57).”
BackgroundInfluentialFunctional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
“factor 4 (HNF4), and retinoid X receptor (RXR) [9-20].”
BackgroundPeeters, A., Fraisl, P., van den Berg, S. A. A., van Themaat, E. V. L., van Kampen, A. H. C., Rider, M. H., Takemori, H., van Dijk, K. W., Veldhoven, P. P. V., Carmeliet, P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299727 · Cited by 61
Wei, N., Cheng, Y., Wang, Z., Liu, Y., Luo, C., Liu, L., Chen, L., Xie, Z., Lu, Y., & Feng, Y. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.038 · Cited by 60
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 77
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Steensels, S., Qiao, J., & Ersoy, B. A. (2020) · Metabolites · doi:10.3390/metabo10070283 · Cited by 58
“binding protein (ChREBP) in response to increases in plasma glucose and the nuclear localization of PPARγ coactivator 1 alpha (PGC1α), cAMP response element binding protein (Creb), CREBH, forkhead protein O1 (FOXO1), and hepatocyte nuclear factor 4α (HNF4α) in response to fasting to promote hepatic glucose production…”
BackgroundRegulatory Actions of Glucocorticoid Hormones: From Organisms to Mechanisms
Granner, D. K., Wang, J.-C., & Yamamoto, K. R. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_1 · Cited by 57
“Those gAF proteins increase the affi nity of GR for GBS1 and GBS2, as demonstrated by fl uorescence anisotropy [ 111 ], thereby nucleating assembly of a transcriptional regulatory complex that includes co-regulators SRC-1, CBP/p300, PGC-1, FoxO1, FoxO3, which appear to assemble through protein · protein interactions […”
BackgroundSelf-citationEddy, S. F., Morin, P., & Storey, K. B. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3459-4 · Cited by 68
Tritos, N. A., Mastaitis, J. W., Kokkotou, E. G., Puigserver, P., Spiegelman, B. M., & Maratos–Flier, E. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03961-6 · Cited by 61
Self-citationNyirenda, M., DEAN, S., Lyons, V., Chapman, K. E., & Seckl, J. R. (2006) · Diabetologia · doi:10.1007/s00125-006-0188-5 · Cited by 61
“Conversely, Hnf4a liver-specific knockout mice fail to induce PCK2 during fasting [35].”
BackgroundWang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 58
“[28] Yoon J, Puigserver P, Chen G, et al.”
BackgroundSkeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes
Devarshi, P., McNabney, S., & Henagan, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040831 · Cited by 53
“Various transcriptional factors and coactivators regulate nuclear and mitochondrial gene expression in response to temperature [44], caloric intake [45], and exercise [46].”
BackgroundMcMeekin, L. J., Fox, S. N., Boas, S. M., & Cowell, R. M. (2021) · Cells · doi:10.3390/cells10020352 · Cited by 58
“PGC-1α expression is robustly increased during this state [14,24,49].”
BackgroundSIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
Xu, R., Luo, X., Ye, X., Li, H., Liu, H., Du, Q., & Zhai, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682762 · Cited by 47
“Mitochondria are the main oxygen consumers at the crossroads of apoptotic pathways induced by anticancer agents, and excess mitochondrial activity leads to local hypoxia in the tumor microenvironment (Figure 3) (112, 113).”
BackgroundUsing Prior Knowledge to Improve Genetic Network Reconstruction from Microarray Data
Le, P. P., Bahl, A., & Ungar, L. (2004) · In Silico Biology · doi:10.3233/isb-00137 · Cited by 65
Effect of intrauterine growth retardation on liver and long-term metabolic risk
Cianfarani, S., Agostoni, C. V., Bedogni, G., Canani, R. B., Brambilla, P., Nobili, V., & Pietrobelli, A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.54 · Cited by 60
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
Gonzalez-Rellan, M. J., Fernandez, U., Parracho, T., Nóvoa, E., Fondevila, M. F., Lima, N. D. S., Ramos, L., Rodríguez, A., Serrano‐Maciá, M., Pérez‐Mejías, G., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.003 · Cited by 55
PGC-1α Determines Light Damage Susceptibility of the Murine Retina
Egger, A., Samardzija, M., Sothilingam, V., Tanimoto, N., Lange, C., Salatino, S., Fang, L., Garrido, M. G., Beck, S. C., Okoniewski, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031272 · Cited by 60
“In both cases, the tissue-specific knockout models exhibit the phenotype that is expected based on in vivo gain-of-function experiments [34,35].”
Buler, M., Aatsinki, S.-M., Izzi, V., & Hakkola, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049863 · Cited by 52
“Intriguingly, however, hepatic expression of PGC-1a is induced in several mouse models of diabetes [41], suggesting that in the actual diabetic state, hepatic metabolic regulation differs from the high-fat diet model mentioned above.”
BackgroundBuler, M., Aatsinki, S., Skoumal, R., Komka, Z., Tóth, M., Kerkelä, R., Georgiadi, A., Kersten, S., & Hakkola, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302356 · Cited by 62
“On the other hand, pathological, extended activation of PGC-1 is observed in obesity and diabetes (10).”
BackgroundRNF34 Is a Cold-Regulated E3 Ubiquitin Ligase for PGC-1 α and Modulates Brown Fat Cell Metabolism
Wei, P. Y., Pan, D., Mao, C., & Wang, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05674-11 · Cited by 56
“naling (12, 22, 28, 33) and suggests that additional mechanisms”
BackgroundPGC-1β regulates angiogenesis in skeletal muscle
Rowe, G. C., Jang, C., Patten, I. S., & Arany, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00681.2010 · Cited by 53
“In addition, each coactivator has unique functions in different tissues, such as control of gluconeogenesis in liver by PGC-1 or macrophage differentiation by PGC-1 (13, 14, 36, 39, 45).”
Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma
Crippa, S., Ancey, P., Vázquez, J., Angelino, P., Rougemont, A., Guettier, C., Zoete, V., Delorenzi, M., Michielin, O. A., & Meylan, E. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707814 · Cited by 54
Sato, H., Hoshi, M., Ikeda, F., Fujiyuki, T., Yoneda, M., & Kai, C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009841 · Cited by 54
Calabuig-Navarro, V., Yamauchi, J., Lee, S., Zhang, T., Liu, Y., Sadlek, K., Coudriet, G. M., Piganelli, J. D., Jiang, C., Miller, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650994 · Cited by 56
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.